Welcome to our dedicated page for Camtek SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Camtek Ltd. filings document foreign-issuer current reports on operating results, customer orders, investor presentations, material agreements, capital structure and governance. The company’s Form 6-K disclosures include financial-result releases, order announcements for semiconductor inspection and metrology systems, and operating and financial review materials.
Camtek’s regulatory record also covers capital-structure activity, including convertible senior notes due 2030, and risk disclosures tied to semiconductor capital spending, demand for HPC, HBM and chiplet devices, global trade and export restrictions, and geographic concentration in Asia Pacific markets. These filings describe the company as a Nasdaq- and TASE-listed supplier serving IDMs, OSATs and foundries.
CAMT submission of Form 144 reporting proposed or past resale activity in ordinary shares by a holder. The filing lists two groups of Restricted Stock Units granted on 01/16/2023 (3,049 units) and 01/24/2022 (4,516 units) and discloses three reported sales during the past three months: $197,085.00 on 11/26/2025 (1,877 shares), $250,768.00 on 12/02/2025 (2,239 shares), and $368,760.90 on 02/24/2026 (2,271 shares).
Form 144 notice for proposed resale of ordinary shares. The filing names Oppenheimer & Co. Inc. as the broker and indicates 150 ordinary shares tied to an Employee Stock Option Plan are to be sold on 02/25/2026 with cash upon exercise as the method. The excerpt also reports that Ben Arie Mordechay sold 3,908 ordinary shares on 12/03/2025 for $466,715.25.
CAMT (ordinary shares): Moshe Eisenberg filed a Form 144 notifying a proposed sale of ordinary shares. The filing shows recent dispositions: 4,045 shares on 11/24/2025 for $398,988.10, 2,328 shares on 12/08/2025 for $274,533.72, 619 shares on 12/10/2025 for $74,280.00, and 3,369 shares on 02/19/2026 for $523,433.11.
CAMT reported insider sale activity by director Orit Geva-Dvash. The filing lists two dispositions of Ordinary shares: 11/26/2025 sale of 1,877 shares for $197,085.00 and 12/02/2025 sale of 2,239 shares for $250,768.00.
The transactions are presented on a Form 144 notification of proposed sale under securities rules; the entries identify the broker as Oppenheimer & Co. Inc. and the exchange as NASDAQ.
Ramy Langer reported a sale of 1,512 ordinary shares on 11/26/2025. The filing shows aggregate proceeds of $157,867.92 from that sale.
The excerpt lists shares outstanding of 45,449,306 as of 02/19/2026 as a context figure.
Camtek Ltd. reporting proposed and completed insider sales of ordinary shares by Moshe Eisenberg. The filing lists three completed transactions: 4,045 shares on 11/24/2025 for $398,988.10, 2,328 shares on 12/08/2025 for $274,533.72, and 619 shares on 12/10/2025 for $74,280.00. The form also shows 11,129 restricted stock units dated 01/16/2023.
Camtek Ltd. reported record results for 2025, with revenues rising 16% to $496.1M and fourth-quarter revenue up 9% year over year to $128.1M. GAAP gross margin improved to 50.5%, while non-GAAP gross margin reached 51.6%, reflecting strong profitability.
Non-GAAP net income grew to $159.0M, or $3.26 per diluted share, compared with $138.6M and $2.83 in 2024. GAAP net income declined to $50.7M due mainly to an $88.7M loss from extinguishment of capital notes. Operating cash flow was $142.6M, and cash, deposits and marketable securities reached $851.1M as of December 31, 2025. Management expects double-digit revenue growth in 2026 and guides first-quarter 2026 revenue to around $120M, citing strong AI-driven demand and recent orders totaling $45M.
Migdal Insurance & Financial Holdings Ltd. has filed a beneficial ownership report showing a 5.1% stake in Camtek Ltd. The filing states Migdal and its subsidiaries collectively hold 2,332,037 ordinary shares, with no sole voting or dispositive power, only shared authority.
The shares are held through various Migdal subsidiaries for the benefit of policyholders, pension and provident fund members, mutual fund investors, portfolio clients and proprietary (“nostro”) accounts. Migdal and its subsidiaries formally disclaim forming a group and any beneficial ownership beyond their actual economic interest.
The signatories also certify that the Camtek shares were not acquired, and are not held, to change or influence control of Camtek, but as part of investment management activities.
Wasatch Advisors filed an amended Schedule 13G reporting its beneficial ownership of 3,167,997 Camtek Ltd ordinary shares, representing 6.9% of the class as of 12/31/2025. Wasatch has sole voting power over 2,139,557 shares and sole dispositive power over 3,167,997 shares.
The firm states the Camtek shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Camtek. The filing is signed by CEO Mike Yeates on behalf of Wasatch Advisors.
Camtek Ltd. reported a new Hawk systems order of about $25 million from a tier‑1 customer for AI applications. This order follows several smaller repeat orders from the same customer, bringing the total Hawk orders from this customer to $45 million for delivery in 2026.
The Hawk is Camtek’s latest inspection and metrology platform, aimed at advanced packaging uses such as High Bandwidth Memory, chiplets, hybrid bonding, FE applications and wafers with up to 500 million micro‑bumps. Management says these orders highlight confidence in Hawk’s capabilities and Camtek’s role in enabling advanced AI and high‑performance computing applications.